SGLT2 inhibitor short-term efficacy and SYNTAX score association in coronary heart disease retinopathy: a propensity score matching study.

Similarly, in the AMI subgroup analysis of the primary CHD + T2DM cohort, the effect of short-term SGLT2 inhibitor use did not reach statistical significance ( P > 0.05; Supplementary Table S22 ), which is likely attributable to the substantially reduced sample size in this particular subgroup analysis that critically constrained the statistical power.

also in 111,027 other papers